Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Vaccination and Plasma Biomarkers of Alzheimer's Disease
NCT05183516Phase 2Unknown
- Sponsor
- Mindful Diagnostics and Therapeutics, LLC
- Start
- May 2023
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of tdap vaccine in Alzheimer's disease (AD), sponsored by Mindful Diagnostics and Therapeutics, LLC. Status: unknown.
02
Drugs
tdap vaccine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05183516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183516.